The effect of 5,8,11-eicosatriynoic acid, a widely used lipoxygenase inhibitor, on Ca 2π fate in Madin Darby canine kidney cells was examined by using fura-2 as a Ca 2π probe. At concentrations between 2-100 mM 5, ] i increases, but adding La 3π during the decay phase had no effect. 5,8,11-Eicosatriynoic acid-induced Ca 2π release was not altered by inhibiting phospholipase C with 2 mM 1-(6-((17b-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione (U73122), but was decreased by 60% by 40 mM aristolochic acid. Several other lipoxygenase inhibitors such as baicalein (50 mM), 5.8.11.14-eicosatetraynoic acid (ETYA; 0.1-0.2 mM), caffeic acid (5-50 mM), esculetin (5-50 mM), a-pentyl-3-(2-quinolinylmethoxy)-benzenemethanol (REV-5901; 0.1-0.2 mM) and a-pentyl-4-(2-quinolinylmethoxy)-benzenemethanol (L-655238; 80-100 mM) had no effect on [Ca 2π ] i . Collectively, the data suggest that the lipoxygenase inhibitor 5,8,11-eicosatriynoic acid induced a [Ca 2π ] i increase in renal tubular cells concentration-dependently, by releasing intracellular Ca 2π from multiple stores in an inositol 1,4,5-trisphosphate-independent manner, and by inducing extracellular Ca 2π influx in a La 3π -sensitive manner.